Prerequisite of doing clinical trial with drugs in COVID-19 patients: Situational experience

Prerequisite of doing clinical trial with drugs in COVID-19 patients: Situational experience

Bibliographic Details
Main Authors:	Pugazhenthan Thangaraju, Atul Jindal
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Perspectives in Clinical Research
Online Access:	http://www.picronline.org/article.asp?issn=2229-3485;year=2020;volume=11;issue=3;spage=135;epage=135;aulast=Thangaraju

Similar Items

COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice?
by: Pugazhenthan Thangaraju, et al.
Published: (2020-06-01)

COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

COVID-19 and leprosy-hurdles and possible solutions
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Vigilance in selection of low-dose versus high-dose steroids in COVID-19
by: Pugazhenthan Thangaraju, et al.
Published: (2021-08-01)

Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs
by: Pugazhenthan Thangaraju, et al.
Published: (2017-01-01)

COVID 19'da N95 maskesinin yeniden kullanımı pandemik stratejiler ve ihtiyat
by: Pugazhenthan Thangaraju, et al.
Published: (2020-09-01)

News from regulatory corner: Safety communication and recent drug approvals
by: Pugazhenthan Thangaraju, et al.
Published: (2018-01-01)

Violence against doctor – few points to be focussed
by: Pugazhenthan Thangaraju
Published: (2020-01-01)

First mobile application - Lepra reaction basic management guide - Stress on steroids
by: Pugazhenthan Thangaraju
Published: (2018-01-01)

Clinical trials on drug repositioning for COVID-19 treatment
by: Sandro G. Viveiros Rosa, et al.
Published: (2020-03-01)

Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays
by: Rijkers Ger T, et al.
Published: (2009-09-01)

Preeminence and prerequisites of sample size calculations in clinical trials
by: Richa Singhal, et al.
Published: (2015-01-01)

Single-dose rifampicin: What current World Health Organization guidelines emphasis and practical special attention?
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Medical residents: Research and publication priorities/confusions
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

DSÖ lepra tedavi kılavuzu: farmakovijilansa odaklanma
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-06-01)

Cüzzamın yeniden alevlenmesine yönelik mücadele stratejileri: Vurgulanması gereken noktalar
by: Sajitha VENKATESAN, et al.
Published: (2019-12-01)

Responding to the Global Guidelines for the Prevention of Surgical Site Infection, 2018: A focus on surgical antibiotic prophylaxis prolongation
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Dünya Sağlık Örgütünün 2019'da küresel sağlığa tehdit ettiğini belirttiği on tehditten biri: Antimikrobiyal direnç
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-09-01)

Clofazimine induced methemoglobinemia –Points to be focussed
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Government of India initiative against leprosy—We should be aware
by: Sajitha Venkatesan, et al.
Published: (2019-01-01)

De novo histoid leprosy - Further points of focus
by: Sajitha Venkatesan, et al.

Current treatment guideline by the World Health Organization against leprosy: A positive focus
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Leprosy in Children: Needs for Active Intervention
by: Pugazhenthan Thangaraju, et al.
Published: (2018-01-01)

Monotherapy with liraglutide – Points to be focussed
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19
by: Rory J. Malek, et al.
Published: (2021-12-01)

COVID-19 Clinical Trials
by: Bonnie Ky, MD, MSCE, et al.
Published: (2020-06-01)

Integration as Didactic Prerequisite for Creating Situations of Axiological Choice to be Made by Students
by: Brizhak Zinaida, et al.
Published: (2019-01-01)

CREATING THE SITUATION OF SUCCESS IN THE HUMAN SCIENCES – A PREREQUISITE FOR THE HUMANIZATION OF EDUCATION
by: Ayta Sakun, et al.
Published: (2020-09-01)

Named terminologies of patient-centered – A focus respective to stigmatized disease
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Retrospective analysis of drug prescription statistics in a tertiary care center in India: Recommendations for promoting prudent utilization of drugs
by: Ajaya Kumar Sahoo, et al.
Published: (2020-01-01)

The impact of COVID-19 on the clinical trial.
by: Zhimin Chen, et al.
Published: (2021-01-01)

Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients
by: Subbaya Subramanian, et al.
Published: (2020-06-01)

Management of liver disease patients in different clinical situations during COVID-19 pandemic
by: Samy Zaky, et al.
Published: (2021-03-01)

Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients
by: Liwen Wei, et al.
Published: (2021-06-01)

COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic Analysis
by: Wang B, et al.
Published: (2020-11-01)

A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
by: Bárbara Costa, et al.
Published: (2021-05-01)

Impact of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials
by: Audisio, K., et al.
Published: (2022)

Managing intravitreal injections in adults in COVID-19 and post-COVID-19 era- Initial experiences
by: Divya Agarwal, et al.
Published: (2020-01-01)

Drug supply situation in Rwanda during COVID-19: issues, efforts and challenges
by: Theogene Uwizeyimana, et al.
Published: (2021-01-01)

Demographic situation in the regions of Ukraine as a prerequisite of labor potential formation and development
by: Lyudmila Melnik, et al.
Published: (2019-12-01)